Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Opko Health Inc (NQ: OPK ) 1.510 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Opko Health Inc < Previous 1 2 3 4 5 6 Next > The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs July 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety Earnings Scheduled For July 29, 2021 July 29, 2021 Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter. • Cohen & Co (AMEX:COHN) is... Via Benzinga The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More July 25, 2021 Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start... Via Benzinga Exposures Product Safety Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week July 16, 2021 The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news. Via The Motley Fool Analyzing OPKO Health's Unusual Options Activity July 15, 2021 OPKO Health (NASDAQ:OPK) shares experienced unusual options activity on Thursday. The stock price moved up to $3.56 following the option alert. Sentiment: BULLISH Option Type:... Via Benzinga OPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant Epilepsy July 12, 2021 OPKO Health Inc (NASDAQ: OPK) has entered into an exclusive worldwide agreement with privately-held CAMP4 Therapeutics Corporation (CAMP4) to develop,... Via Benzinga OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China June 21, 2021 OPKO Health Inc's (NASDAQ: OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2021 June 21, 2021 Upgrades B of A Securities upgraded the previous rating for Cimarex Energy Co (NYSE: Via Benzinga OPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon Therapeutics June 17, 2021 OPKO Health Inc's (NASDAQ: OPK) subsidiary, EirGen Pharma Ltd, has agreed to sell one of its facilities in Waterford, Ireland, to Horizon Therapeutics plc... Via Benzinga Cramer Shares His Thoughts On MP Materials, Nokia And More In 'Lightning Round' May 23, 2021 On CNBC's "Mad Money Lightning Round," Jim Cramer said he would pass on Opko Health Inc. (NASDAQ: OPK). BOSTON OMAHA Corp (NASDAQ: BOMN) is a hard pass, said Cramer... Via Benzinga 10 Health Care Stocks Showing Unusual Options Activity In Today's Session May 14, 2021 This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... Via Benzinga Opko Health (OPK) Q1 2021 Earnings Call Transcript April 28, 2021 OPK earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial OPKO Health: Q1 Earnings Insights April 28, 2021 Shares of OPKO Health (NASDAQ:OPK) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 155.56% over the past year to $0.... Via Benzinga The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping April 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... Via Benzinga Exposures Product Safety Earnings Scheduled For April 28, 2021 April 28, 2021 Companies Reporting Before The Bell • M/I Homes (NYSE:MHO) is likely to report quarterly earnings at $1.51 per share on revenue of $758.77 million. • Melco... Via Benzinga The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx April 24, 2021 Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
